학술논문

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Document Type
article
Author
Meng, BoKemp, Steven APapa, GuidoDatir, RawlingsFerreira, Isabella ATMMarelli, SaraHarvey, William TLytras, SpyrosMohamed, AhmedGallo, GiuliaThakur, NaziaCollier, Dami AMlcochova, PetraConsortium, The COVID-19 Genomics UKRobson, Samuel CLoman, Nicholas JConnor, Thomas RGolubchik, TanyaNunez, Rocio T MartinezLudden, CatherineCorden, SallyJohnston, IanBonsall, DavidSmith, Colin PAwan, Ali RBucca, GiseldaTorok, M EsteeSaeed, KordoPrieto, Jacqui AJackson, David KHamilton, William LSnell, Luke BMoore, CatherineHarrison, Ewan MGoncalves, SoniaFairley, Derek JLoose, Matthew WWatkins, JoanneLivett, RichMoses, SamuelAmato, RobertoNicholls, SamBull, MatthewSmith, Darren LBarrett, JeffAanensen, David MCurran, Martin DParmar, SurendraAggarwal, DineshShepherd, James GParker, Matthew DGlaysher, SharonBashton, MatthewUnderwood, Anthony PPacchiarini, NicoleLoveson, Katie FTempleton, Kate ELangford, Cordelia FSillitoe, Johnde Silva, Thushan IWang, DennisKwiatkowski, DominicRambaut, AndrewO’Grady, JustinCottrell, SimonHolden, Matthew TGThomson, Emma COsman, HusamAndersson, MoniqueChauhan, Anoop JHassan-Ibrahim, Mohammed OLawniczak, MaraAlderton, AlexChand, MeeraConstantinidou, ChrystalaUnnikrishnan, MeeraDarby, Alistair CHiscox, Julian APaterson, SteveMartincorena, InigoVolz, Erik MPage, Andrew JPybus, Oliver GBassett, Andrew RAriani, Cristina VChapman, Michael H SpencerLi, Kathy KShah, Rajiv NJesudason, Natasha GTaha, YusriMcHugh, Martin PDewar, RebeccaJahun, Aminu SMcMurray, ClairePandey, SarojiniMcKenna, James PNelson, AndrewYoung, Gregory RMcCann, Clare MElliott, Scott
Source
Cell Reports. 35(13)
Subject
Emerging Infectious Diseases
Infectious Diseases
Lung
Pneumonia
Good Health and Well Being
Animals
Antibodies
Neutralizing
Antibodies
Viral
COVID-19
Cell Line
Chlorocebus aethiops
HEK293 Cells
Humans
Immune Evasion
Mutation
Pandemics
Phylogeny
Protein Binding
Recurrence
SARS-CoV-2
Spike Glycoprotein
Coronavirus
Vero Cells
COVID-19 Genomics UK (COG-UK) Consortium
Alpha variant
B.1.1.7
antibody escape
deletion
infectivity
neutralizing antibodies
resistance
spike mutation
Biochemistry and Cell Biology
Medical Physiology
Language
Abstract
We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although ΔH69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. ΔH69/V70 is able to partially rescue infectivity of spike proteins that have acquired N439K and Y453F escape mutations by increased spike incorporation. In addition, replacement of the H69 and V70 residues in the Alpha variant B.1.1.7 spike (where ΔH69/V70 occurs naturally) impairs spike incorporation and entry efficiency of the B.1.1.7 spike pseudotyped virus. Alpha variant B.1.1.7 spike mediates faster kinetics of cell-cell fusion than wild-type Wuhan-1 D614G, dependent on ΔH69/V70. Therefore, as ΔH69/V70 compensates for immune escape mutations that impair infectivity, continued surveillance for deletions with functional effects is warranted.